London Ontario, Canada - December 20, 2011. From left to right Dr. Sang Kyun Lee, Dr. Chil-Yong Kang and Dr. Dong Joon Kim representing Sumagen share in the success at a press conference announcing the approval for the HIV/AIDS vaccine SAV001 that was developed at the University of Western Ontario b

---

London Ontario, Canada - December 20, 2011. From left to right Dr. Sang Kyun Lee, Dr. Chil-Yong Kang and Dr. Dong Joon Kim representing Sumagen share in the success at a press conference announcing the approval for the HIV/AIDS vaccine SAV001 that was developed at the University of Western Ontario by Dr. Chi-Yong Kang and his team to proceed with human clinical trials. The first trial will begin in January 2012.

---

Size: 3600px × 2400px
Photo credit: © Mark Spowart / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: acquired, aids, canada, chil-yong, clinical, deficiency, discovery, dong, dr., hiv, human, immune, immunodeficiency, joon, kang, kim, kyun, lee, london, medicine, ontario, research, sang, science, sumagen, syndrome, trial, trials, university, uwo, vaccine, virus, western